PROCEPT BioRobotics Corp
PRCT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001588978
In the last 90 days, PROCEPT BioRobotics Corp insiders filed 1 open-market purchase and 3 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in PROCEPT BioRobotics Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- +8 vs. Q2 2023
- Shares held
- 44.5M
- +8.46M (+23.5%) vs. Q2 2023
- Total value
- $1.46B
- +$188.5M (+14.8%) vs. Q2 2023
- New holders
- 22
- 64 more added
- Sold out
- 14
- 27 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 253 | $1.24B |
| Q1 2026 | 257 | $1.40B |
| Q4 2025 | 263 | $1.77B |
| Q3 2025 | 242 | $2.06B |
| Q2 2025 | 271 | $3.07B |
| Q1 2025 | 279 | $2.94B |
| Q4 2024 | 281 | $4.06B |
| Q3 2024 | 250 | $3.65B |
| Q2 2024 | 202 | $2.69B |
| Q1 2024 | 162 | $2.26B |
| Q4 2023 | 145 | $1.91B |
| Q3 2023 | 127 | $1.46B |
| Q2 2023 | 120 | $1.27B |
| Q1 2023 | 116 | $937.6M |
| Q4 2022 | 116 | $1.36B |
| Q3 2022 | 104 | $1.40B |
| Q2 2022 | 96 | $1.14B |
| Q1 2022 | 58 | $1.08B |
| Q4 2021 | 60 | $732.3M |
| Q3 2021 | 58 | $1.03B |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding PROCEPT BioRobotics Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Handelsbanken Fonder AB | 6,900 | $226.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 5,917 | $194.1K | 0.00% | −14,773−71.4% | Reduced |
| Amalgamated Bank | 5,488 | $180.0K | 0.00% | +442+8.8% | Added |
| Royal Bank of Canada | 4,840 | $159.0K | 0.00% | +1,290+36.3% | Added |
| Ameritas Investment Partners, Inc. | 3,586 | $117.7K | 0.00% | +605+20.3% | Added |
| UBS Group AG | 3,436 | $112.7K | 0.00% | −15,547−81.9% | Reduced |
| SG Americas Securities, LLC | 3,347 | $110.0K | 0.00% | −8,450−71.6% | Reduced |
| Metropolitan Life Insurance Co | 2,175 | $71.4K | 0.00% | +186+9.4% | Added |
| Ronald Blue Trust, Inc. | 2,009 | $71.0K | 0.00% | +2,009 | New |
| Tower Research Capital LLC (TRC) | 2,087 | $68.5K | 0.00% | −842−28.7% | Reduced |
| Shell Asset Management Co | 2,055 | $67.0K | 0.00% | −32−1.5% | Reduced |
| US Bancorp | 1,284 | $42.1K | 0.00% | +83+6.9% | Added |
| Advisor Group Holdings, Inc. | 859 | $28.2K | 0.00% | −571−39.9% | Reduced |
| Nisa Investment Advisors, LLC | 705 | $23.1K | 0.00% | 00.0% | Unchanged |
| Natixis | 644 | $21.1K | 0.00% | −44,258−98.6% | Reduced |
| Quadrant Capital Group LLC | 312 | $10.2K | 0.00% | +289+1,256.5% | Added |
| Comerica Bank | 263 | $8.63K | 0.00% | +263 | New |
| MCF Advisors LLC | 161 | $5.28K | 0.00% | +31+23.8% | Added |
| Chilton Capital Management LLC | 125 | $4.10K | 0.00% | 00.0% | Unchanged |
| Manchester Capital Management LLC | 60 | $1.97K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 56 | $1.84K | 0.00% | +6+12.0% | Added |
| The PNC Financial Services Group, Inc. | 34 | $1.12K | 0.00% | +34 | New |
| CWM, LLC | 16 | $1.00K | 0.00% | +4+33.3% | Added |
| Massmutual Trust Co FSB | 19 | $623 | 0.00% | +11+137.5% | Added |
| Farther Finance Advisors, LLC | 5 | $164 | 0.00% | +5 | New |
| Crewe Advisors LLC | 4 | $132 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 4 | $0 | 0.00% | −1−20.0% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −318,348−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −295,544−100.0% | Sold out |
| Trustees of the University of Pennsylvania | 0 | $0 | 0.00% | −90,914−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −61,730−100.0% | Sold out |
| Osterweis Capital Management Inc | 0 | $0 | 0.00% | −56,970−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −19,869−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −17,100−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −10,820−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −10,750−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −7,409−100.0% | Sold out |
| Glass Jacobson Investment Advisors llc | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| O'Dell Group, LLC | 0 | $0 | 0.00% | −1,575−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Vigilant Capital Management, LLC | – | – | – | – | Not filed |